Stock listing

Copenhagen:NOVOB Novo Nordisk A/S Aktie

Home listing (Copenhagen) of Novo Nordisk A/S

Follow Novo Nordisk A/S into a list and get an email when it puts out news.

Share price · OMXCOP:NOVO_B

264.50 DKK -6.95 (-2.6%)

Close on Nov 20, 2026

Past year -15.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
260.35 – 266.15 DKKNov 20, 2026
Volume
4.53M sharesNov 20, 2026
Market cap
881.7B DKKAt the close on Nov 20, 2026 · price × 3.33B shares outstanding
52-week range
224.25 – 409.95 DKKLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
1.34B DKKMedian day 4.43M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Novo Nordisk A/S logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:NVO$37.82 USD-1.05 (-2.7%)13,068,177$38.44$39.12$37.75$38.87Close on Nov 20, 2026
Xetra:NOV€35.18 EUR-0.265 (-0.7%)199,309€35.18€35.60€34.85€35.44Close on Nov 20, 2026
TSX:NOVO$16.72 CAD-0.58 (-3.4%)6,394$17.26$17.27$16.72$17.30Close on Nov 20, 2026
OTC:NONOF$37.76 USD-1.745 (-4.4%)9,877$37.51$39.00$37.51$39.50Close on Nov 20, 2026
Cboe Canada:NVON$4.17 CAD-0.07 (-1.7%)21,875$4.30$4.31$4.17$4.24Close on Nov 20, 2026
Frankfurt:NOV€34.50 EUR-0.865 (-2.4%)—€35.10€35.50€34.50€35.37Close on Nov 20, 2026
B3:N1VO3429.00 BRL+0.12 (+0.4%)16,07228.3029.3528.2728.88Close on Nov 19, 2026
Frankfurt:NOVA€34.36 EUR-0.90 (-2.6%)456€35.00€35.66€34.36€35.26Close on Nov 20, 2026
LSE:0TDD$38.29 USD-0.55 (-1.4%)73,490$38.46$39.12$38.21$38.84Close on Nov 20, 2026
Dusseldorf:NOVA€34.82 EUR-0.48 (-1.4%)—€34.86€35.34€34.82€35.30Close on Nov 20, 2026
Hamburg:NOV€35.27 EUR-0.125 (-0.4%)10€34.99€35.27€34.99€35.40Close on Nov 20, 2026
Dusseldorf:NOV€34.72 EUR-0.645 (-1.8%)250€34.91€35.35€34.72€35.37Close on Nov 20, 2026
Munich:NOV€35.06 EUR-1.075 (-3.0%)—€35.16€35.16€35.03€36.13Close on Nov 20, 2026
Munich:NOVA€35.16 EUR-0.96 (-2.7%)—€35.16€35.16€35.16€36.12Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OMXCOP:NOVO_B · DKK, adjusted for splits

DayCloseChange%OpenHighLowVolume
264.50-6.95-2.6%265.00266.15260.354,534,446
271.45-4.05-1.5%275.50277.70269.454,462,338
275.50-9.75-3.4%283.80283.80274.055,920,442
285.25+6.80+2.4%283.00288.45282.605,004,913
278.45+2.70+1.0%274.75278.45274.003,990,600
275.75+3.05+1.1%276.90279.65271.207,230,342
272.70+1.20+0.4%271.50274.45270.404,338,121
271.50+2.05+0.8%276.90278.00270.453,567,454
269.45-1.80-0.7%267.00271.15265.605,243,688
271.25-13.95-4.9%282.85282.85268.458,796,632
285.20+15.05+5.6%280.15287.95273.1012,125,742
270.15-0.050.0%270.45271.00267.154,426,756
270.20+4.10+1.5%264.00270.20263.753,649,526
266.10+5.75+2.2%264.80268.40262.906,661,279
260.35+5.35+2.1%255.70261.50254.756,307,372
255.00-4.50-1.7%258.70260.65254.955,015,221
259.50-0.95-0.4%260.45262.25258.204,300,070
260.45+0.30+0.1%260.70263.30259.853,209,440
260.15-4.60-1.7%264.60264.60258.504,168,570
264.75+3.05+1.2%260.90264.75260.354,126,144
261.70+0.50+0.2%262.30262.75259.253,706,533
261.20+3.20+1.2%256.95261.20256.603,653,012
258.00-1.60-0.6%260.00260.65255.95288,062
259.60-3.85-1.5%261.00262.15259.355,455,009
263.45+7.50+2.9%255.50263.45254.256,214,304
255.95-0.70-0.3%253.25258.00252.303,878,749
256.65+0.25+0.1%258.45260.40255.804,055,271
256.40+1.15+0.5%257.15259.80255.654,112,518
255.25+5.35+2.1%252.50257.80252.005,041,888
249.90-4.00-1.6%253.90254.95249.903,784,117
253.90+8.35+3.4%248.25254.25247.506,162,474
245.55-1.25-0.5%251.45252.00244.504,938,995
246.80-1.95-0.8%249.05249.15243.155,784,986
248.75-1.25-0.5%246.60250.50246.154,305,929
250.00-3.20-1.3%250.70252.55247.955,772,781
253.20+1.55+0.6%249.75255.15249.107,931,061
251.65-0.60-0.2%252.50254.80250.854,664,422
252.25-0.75-0.3%254.30255.90251.404,679,253
253.000.000.0%254.00255.00252.003,906,196
253.00+0.75+0.3%250.00254.20247.057,386,035
252.25-6.55-2.5%256.00260.45252.255,754,249
258.80-1.20-0.5%259.05260.70255.407,392,648
260.00-21.55-7.7%284.30284.30257.9013,903,990
281.55+2.20+0.8%281.00284.70279.209,279,685
279.35+6.75+2.5%273.40279.90272.255,230,534
272.60-3.30-1.2%275.90280.40272.104,157,196
275.90-4.50-1.6%282.50283.05275.403,106,990
280.40+3.95+1.4%277.15283.65277.103,582,380
276.45-9.85-3.4%282.00283.95275.505,300,727
286.30-2.60-0.9%287.55290.45285.703,211,322
288.90-3.10-1.1%290.00291.45287.804,429,973
292.00-6.95-2.3%297.00298.20291.653,892,795
298.95+0.050.0%297.10299.40296.551,797,150
298.90-2.65-0.9%304.00305.45296.703,129,002
301.55-0.100.0%301.65309.90299.954,776,219
301.65+7.75+2.6%293.40302.70292.654,095,568
293.90+1.50+0.5%290.90297.80290.903,512,788
292.40-3.10-1.0%293.45294.25289.855,554,486
295.50+0.25+0.1%294.60301.10294.004,184,104
295.25-9.70-3.2%300.50301.05293.455,695,327
304.95-2.85-0.9%311.00314.85304.853,461,972
307.80+8.55+2.9%302.90309.35302.604,451,386
299.25-1.60-0.5%298.15304.45298.003,241,705
300.85+4.70+1.6%296.10300.85294.253,754,463
296.15-3.30-1.1%299.40301.10295.803,084,254

Splits

3 splits since 2007 · OMXCOP:NOVO_B · every price before a split is adjusted for it

DayRatioWhat
2-for-1Split
5-for-1Split
2-for-1Split
Ticker
Copenhagen:NOVO_B
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Copenhagen
Currency
DKK

What changed lately

Latest news

All Novo Nordisk A/S news

Novo Nordisk A/S on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
85 in the last 12 months · 113 in all · newest Sep 29, 2026 · oldest 2025
Calls
26 calls with a replay · 26 with a transcript · latest Aug 5, 2026
Decks
230 decks · latest Sep 21, 2026

Where Novo Nordisk A/S is listed

ListingExchangeCountryCurrency
Copenhagen:NOVOB · Home listing · This pageCopenhagenDenmarkDKK
NYSE:NVONYSEUnited StatesUSD
Xetra:NOVXetraGermanyEUR
gettex:NOVgettexGermanyEUR
Tradegate:NOVTradegateGermanyEUR
TSX:NOVOTSXCanadaCAD
LS Exchange:A3EU6FLS ExchangeGermanyEUR
Aquis:NOVOBCAquisUnited KingdomDKK
SET:NOVOB80SETThailandTHB
gettex:NOVAgettexGermanyEUR
LSIN:0QIULSINUnited KingdomDKK
OTC:NONOFOTCUnited StatesUSD
BMV:NVONBMVMexicoMXN
Cboe Canada:NVONCboe CanadaCanadaCAD
Tradegate:NOVATradegateGermanyEUR
Stuttgart:NOVStuttgartGermanyEUR
Frankfurt:NOVFrankfurtGermanyEUR
Lang & Schwarz:A3EU6FLang & SchwarzGermanyEUR
B3:N1VO34B3BrazilBRL
Cboe Canada:NOVOCboe CanadaCanadaCAD
BOATS:NVOBOATSUnited StatesUSD
GPW:NVOGPWPolandPLN
LS Exchange:866931LS ExchangeGermanyEUR
Aquis:NOVOBCAquisUnited KingdomDKK
Turquoise:NOVOBCTurquoiseUnited KingdomDKK
BMV:NOVOBNBMVMexicoMXN
Frankfurt:NOVAFrankfurtGermanyEUR
LSE:0TDDLSEUnited KingdomUSD
BX Swiss:NOVBX SwissSwitzerlandCHF
VIE:NNO2ViennaAustriaEUR
BX Swiss:NVOBX SwissSwitzerlandCHF
Aquis:NOVDAquisUnited KingdomEUR
Lang & Schwarz:866931Lang & SchwarzGermanyEUR
Dusseldorf:NOVADusseldorfGermanyEUR
BIVA:NOVOBNBIVAMexicoMXN
Hamburg:NOVHamburgGermanyEUR
Stuttgart:NOVAStuttgartGermanyEUR
Aquis:NOVDAquisUnited KingdomEUR
Frankfurt:NOV1FrankfurtGermanyEUR
BCBA:NVOBCBAArgentinaARS
Dusseldorf:NOVDusseldorfGermanyEUR
Hanover:NOVHanoverGermanyEUR
Munich:NOVMunichGermanyEUR
Munich:NOVAMunichGermanyEUR
Frankfurt:NOV0FrankfurtGermanyEUR
BSESOF:NOVBSESOFBulgariaEUR
Hamburg:NOVAHamburgGermanyEUR
BCBA:NVOCBCBAArgentinaUSD
BCBA:NVODBCBAArgentinaUSD
BCBA:NVO.CIBCBAArgentinaARS

Valuation

P/E 7.8× against a median of 21.7×: 2nd lowest of 11 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
969.8B DKK
P/E
7.8×
EV/sales
2.9×
EV/EBITDA
5.5×
Price/book
4.0×
Gross margin
82.0%
Operating margin
46.2%
Net margin
33.9%
Debt to equity
0.6×
Beta
No index for this market yet

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Novo Nordisk A/S Class B · OMXCOP:NOVO_BUS$129.4BUS$142.3B7.8×2.9×5.5×4.0×33.9%0.6×n/a
Merck & Company, Inc. · NYSE:MRKUS$329.7BUS$373.8B134×5.5×n/a7.3×3.6%1.2×0.28
Novartis AG · SIX:NOVNUS$287.4BUS$304.7B20.6×n/an/a6.2×n/a0.6×n/a
AstraZeneca PLC · LSE:AZNUS$272.1BUS$298.0B24.6×4.8×14.1×5.3×17.7%0.7×n/a
Pfizer, Inc. · NYSE:PFEUS$156.2BUS$207.8B38.7×3.3×9.6×1.8×6.3%0.7×0.29
Vertex Pharmaceuticals Incorporated · NASDAQ:VRTXUS$130.6BUS$128.8B32.8×9.9×28.4×6.3×30.7%0.2×0.47
Bristol-Myers Squibb Company · NYSE:BMYUS$120.2BUS$151.3B13.0×3.0×n/a5.1×18.5%1.9×0.26
Sanofi SA · EURONEXT:SANUS$111.7BUS$126.9B14.6×2.3×4.7×1.4×13.9%0.3×n/a
GSK plc · LSE:GSKUS$96.63BUS$123.8B17.0×2.8×9.3×3.9×13.0%1.3×n/a
argenx SE · EURONEXT:ARGXUS$58.86BUS$53.72B22.8×6.5×n/a7.0×31.4%0.0×n/a
Roche Holding Ltd · SIX:ROUS$51.16BUS$77.45B3.3×1.1×2.9×1.3×20.9%1.0×n/a
Median of the othersUS$125.4BUS$140.0B21.7×3.3×9.4×5.2×17.7%0.7×0.29

Forecasts

Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.

Price target
299.91 DKK · Analysts' mean
EPS, year to Dec 2026
22.83 · 22 analysts
Revenue, year to Dec 2026
311B · 27 analysts

Team and board

Officers

OfficerRole
Elin JägerSenior Vice President, Chief of Staff to CEO, Transformation & Sustainability
Hong ChowExecutive Vice President, Chief Financial Officer
Thomas Rask NielsenSenior Vice President, Group General Counsel & Legal, Ethics & Compliance, Business Assurance, IP & Security
Emil Kongshøj LarsenExecutive Vice President, Head of North America
Karsten Munk KnudsenExecutive Vice President, Global Operations
Kasper Bødker MejlvangExecutive Vice President, Global Manufacturing & Supply
Martin Holst LangeExecutive Vice President, Global Commercial Strategy and Corporate Affairs
Maziar Mike DoustdarExecutive Vice President, Global R&D
Tania SabroeExecutive Vice President, People, Organisation & Corporate Affairs
Thilde Hummel BøgebjergExecutive Vice President, Global Marketing
Jamey MillarExecutive Vice President, US Operations

Board

DirectorRole
Cees de JongVice chair of the Board of Directors, chair of the Remuneration Committee, member of the Chair Committee, and member of the Audit Committee
Britt Meelby JensenMember of the Board of Directors, member of the Remuneration Committee and member of the Research & Development Committee
Désirée Jantzen AsgreenMember of the Board of Directors (employee representative) and member of the Research & Development Committee
Elisabeth Dahl ChristensenMember of the Board of Directors (employee representative) and member of the Remuneration Committee
Helena SaxonMember of the Board of Directors, member of the People & Governance Committee and member of the Audit Committee
Jan van de WinkelMember of the Board of Directors and chair of the Research & Development Committee
Kasim KutayMember of the Board of Directors, member of the Research & Development Committee
Mette Bøjer JensenMember of the Board of Directors (employee representative), member of the Audit Committee
Ramona SequeiraMember of the Board of Directors, member of the Remuneration Committee and member of the Research & Development Committee
Semsi Kilic MadsenMember of the Board of Directors (employee representative) and member of the People & Governance Committee
Stephan EngelsMember of the Board of Directors, chair of the Audit Committee and member of the People & Governance Committee

Events

Next results
Feb 3, 2027 (expected)

Calls

CallWhenStatus
Novo Nordisk (Copenhagen:NOVO B) Q2 2026 Earnings CallWed, Aug 05, 2026 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q1 2026 Earnings CallWed, May 06, 2026 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q4 2025 Earnings CallWed, Feb 04, 2026 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q3 2025 Earnings CallWed, Nov 05, 2025 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q2 2025 Earnings CallWed, Aug 06, 2025 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q1 2025 Earnings CallWed, May 07, 2025 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q4 2024 Earnings CallWed, Feb 05, 2025 · 11:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q3 2024 Earnings CallWed, Nov 06, 2024 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q2 2024 Earnings CallWed, Aug 07, 2024 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q1 2024 Earnings CallThu, May 02, 2024 · 8:30 AM ETReplay
All 26 calls
CallWhenStatus
Novo Nordisk (Copenhagen:NOVO B) Q4 2023 Earnings CallWed, Jan 31, 2024 · 1:00 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q3 2023 Earnings CallFri, Nov 24, 2023 · 8:00 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q2 2023 Earnings CallThu, Aug 10, 2023 · 10:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q1 2023 Earnings CallThu, May 04, 2023 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q4 2022 Earnings CallWed, Feb 01, 2023 · 8:30 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q3 2022 Earnings CallWed, Nov 02, 2022 · 2:00 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q2 2022 Earnings CallWed, Aug 03, 2022 · 8:30 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q1 2022 Earnings CallFri, Apr 29, 2022 · 2:00 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q4 2021 Earnings CallTue, Feb 22, 2022 · 2:00 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q3 2021 Earnings CallWed, Nov 03, 2021 · 2:00 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q2 2021 Earnings CallWed, Aug 04, 2021 · 1:00 PM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q1 2021 Earnings CallWed, May 05, 2021 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q4 2020 Earnings CallWed, Feb 03, 2021 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q3 2020 Earnings CallFri, Oct 30, 2020 · 8:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q2 2020 Earnings CallThu, Aug 06, 2020 · 7:00 AM ETReplay
Novo Nordisk (Copenhagen:NOVO B) Q1 2020 Earnings CallThu, May 07, 2020 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · Before open+5.6%
Q2 2026Aug 4, 2026 · After close−4.3%
Q1 2026May 5, 2026 · After close+2.5%
Q4 2025Feb 3, 2026 · After close−17.2%
Q3 2025Nov 5, 2025 · Before open−4.5%
Q2 2025Aug 6, 2025 · Before open−5.4%
Q1 2025May 7, 2025 · Before open+1.3%
Q4 2024Feb 4, 2025 · After close+4.5%
Q3 2024Nov 6, 2024 · Before open+0.6%
Q2 2024Aug 7, 2024 · Before open−6.7%
All 20 quarters
QuarterResultsShare move
Q1 2024May 2, 2024 · Before open−2.7%
Q4 2023Jan 31, 2024 · Before open+3.6%
Q3 2023Nov 2, 2023 · Before open+3.2%
Q2 2023Aug 9, 2023 · After close−1.2%
Q1 2023May 4, 2023 · Before open−2.6%
Q4 2022Feb 1, 2023 · Before open−0.1%
Q3 2022Nov 2, 2022 · Before open+7.4%
Q2 2022Aug 3, 2022 · After close+1.0%
Q1 2022Apr 29, 2022 · Before open+5.4%
Q4 2021Feb 1, 2022 · After close+4.4%

Open Events

Decks

DeckKindSlidesDate
Investor Day (September 2026)Investor day14 slidesSep 21, 2026
Investor Day (September 2026)Investor day16 slidesSep 21, 2026
Investor Day (September 2026)Investor day14 slidesSep 21, 2026
Investor Day (September 2026)Investor day13 slidesSep 21, 2026
Investor Day (September 2026)Investor day13 slidesSep 21, 2026
Investor Day (September 2026)Investor day20 slidesSep 21, 2026
Investor Day (September 2026)Investor day13 slidesSep 21, 2026
Investor Day (September 2026)Investor day16 slidesSep 21, 2026
Investor Day (September 2026)Investor day14 slidesSep 21, 2026
Investor Day (September 2026)Investor day16 slidesSep 21, 2026
Show 50 decks
DeckKindSlidesDate
Q2 2026 Earnings PresentationEarnings85 slidesAug 5, 2026
Investor Presentation (June 2026)Investor deck28 slidesJun 7, 2026
Technical Presentation (May 2026)Technical24 slidesMay 7, 2026
Q1 2026 Earnings PresentationEarnings84 slidesMay 6, 2026
Shareholder Meeting (March 2026)Shareholder meeting51 slidesMar 26, 2026
Technical Presentation (March 2026)Technical18 slidesMar 18, 2026
FY2025 Earnings PresentationEarnings121 slidesFeb 4, 2026
67th ASH Annual Meeting and Exposition 2025Conference17 slidesDecember 2025
Shareholder Meeting (November 2025)Shareholder meeting20 slidesNov 14, 2025
Q3 2025 Earnings PresentationEarnings138 slidesNov 5, 2025
Merger or Acquisition (October 2025)Merger or acquisition8 slidesOct 9, 2025
Technical Presentation (September 2025)Technical5 slidesSep 15, 2025
European Society of Cardiology (ESC) Congress together with World Congress of Cardiology 2 (August 2025)Conference15 slidesAug 31, 2025
H1 2025 Earnings PresentationEarnings180 slidesAug 6, 2025
Investor Day (June 2025)Investor day58 slidesJun 22, 2025
Q1 2025 Earnings PresentationEarnings173 slidesMay 7, 2025
Shareholder Meeting (March 2025)Shareholder meeting53 slidesMar 27, 2025
Shareholder Meeting (March 2025)Shareholder meeting53 slidesMar 27, 2025
Shareholder Meeting (February 2025)Shareholder meeting18 slidesFeb 27, 2025
FY2024 Earnings PresentationEarnings164 slidesFeb 5, 2025
Technical Presentation (2025)Technical19 slides2025
Technical Presentation (2025)Technical15 slides2025
Q3 2024 Earnings PresentationEarnings163 slidesNov 6, 2024
Technical Presentation (September 2024)Technical13 slidesSep 5, 2024
H1 2024 Earnings PresentationEarnings159 slidesAug 7, 2024
Q1 2024 Earnings PresentationEarnings159 slidesMay 2, 2024
Shareholder Meeting (March 2024)Shareholder meeting55 slidesMar 21, 2024
Shareholder Meeting (March 2024)Shareholder meeting55 slidesMar 21, 2024
Investor Day (March 2024)Investor day11 slidesMar 8, 2024
Investor Day (March 2024)Investor day18 slidesMar 7, 2024
Investor Day (March 2024)Investor day10 slidesMar 7, 2024
Investor Day (March 2024)Investor day10 slidesMar 7, 2024
Investor Day (March 2024)Investor day13 slidesMar 7, 2024
Investor Day (March 2024)Investor day17 slidesMar 7, 2024
Investor Day (March 2024)Investor day15 slidesMar 7, 2024
Investor Day (March 2024)Investor day10 slidesMar 7, 2024
Investor Day (March 2024)Investor day10 slidesMar 7, 2024
Investor Day (March 2024)Investor day24 slidesMar 7, 2024
Investor Day (March 2024)Investor day24 slidesMar 7, 2024
Investor Day (March 2024)Investor day22 slidesMar 7, 2024

This page holds 50 of 230 decks. Open Decks

Open Decks

Financials

Annual, in DKK

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue309.1B290.4B232.3B177.0B140.8B126.9B122.0B111.8B111.7B111.8B
Cost of revenue58.8B44.5B35.8B28.4B23.7B20.9B20.1B17.6B17.6B17.2B
Gross profit250.3B245.9B196.5B148.5B117.1B106.0B101.9B94.2B94.1B94.6B
Research and development52.0B48.1B32.4B24.0B17.8B15.5B14.2B14.8B14.0B14.6B
Selling, general and administrative5.97B5.28B61.6B4.47B4.05B3.96B4.01B3.92B3.78B3.96B
Operating income127.7B128.3B102.6B74.8B58.6B54.1B52.5B47.2B49.0B48.4B
Depreciation and amortization14.7B8.54B9.41B7.36B6.03B5.75B5.66B3.92B3.18B3.19B
EBITDA142.3B136.9B112.0B82.2B64.7B59.9B58.1B51.2B52.1B51.6B
Interest expense6.78B7.35B845.0M378.0M2.45B390.0M220.0M85.0M90.0M65.0M
Income before tax130.5B127.2B104.7B69.1B59.1B53.1B48.6B47.6B48.7B47.8B
Income tax28.1B26.2B21.0B13.5B11.3B11.0B9.60B8.99B10.6B9.87B
Net income102.4B101.0B83.7B55.5B47.8B42.1B39.0B38.6B38.1B37.9B
Earnings per share, basic23.0622.6718.6712.2210.379.008.197.977.697.48
Earnings per share, diluted23.0322.6318.62

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents26.5B15.7B14.4B12.7B10.7B12.8B15.5B15.6B18.9B18.7B
Short-term investments498.0M10.7B15.8B10.9B6.76B02.30B2.01B
Receivables70.9B71.9B64.8B57.5B46.8B32.2B29.2B26.9B23.6B24.2B
Inventory49.6B40.8B31.8B24.4B19.6B18.5B17.6B16.3B15.4B14.3B
Current assets172.5B161.8B139.6B108.2B85.6B65.8B62.5B59.1B60.1B59.8B
Property, plant and equipment208.4B161.7B66.7B55.4B50.3B50.6B41.9B35.2B30.2B
Goodwill19.8B20.0B4.46B5.09B4.35B0
Total assets542.9B465.6B314.5B241.3B194.5B144.9B125.6B110.8B102.4B97.5B
Accounts payable19.8B17.1B25.6B15.6B8.87B5.72B6.36B6.76B5.61B6.01B
Current liabilities215.7B217.6B169.7B120.9B99.5B70.3B59.0B54.2B47.1B47.4B
Long-term debt118.9B89.7B16.0B20.8B9.65B
Total debt131.0B102.8B27.0B25.8B26.6B10.4B4.48B515.0M1.69B229.0M
Total liabilities348.9B322.1B207.9B157.8B123.8B81.6B68.0B58.9B52.5B52.3B
Shareholders' equity194.0B143.5B106.6B83.5B70.7B63.3B57.6B51.8B49.8B45.3B
Shares outstanding4.45B4.46B4.46B4.54B4.61B4.68B4.76B4.85B4.96B5.07B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations119.1B121.0B108.9B78.9B55.0B52.0B46.8B44.6B41.2B48.3B
Capital spending-60.1B-47.2B-25.8B-14.8B-7.38B-22.1B-11.2B-12.4B-8.65B-8.27B
Free cash flow59.0B73.8B83.1B64.1B47.6B29.9B35.6B32.2B32.5B40.0B
Cash from investing-79.2B-128.9B-43.9B-24.9B-31.6B-22.4B-11.5B-12.1B-6.57B-6.79B
Cash from financing-28.4B8.73B-63.2B-51.8B-25.5B-32.2B-35.5B-34.5B-35.7B-38.9B
Dividends paid-51.8B-44.1B-31.8B-25.3B-21.5B-20.1B-19.4B-19.0B-18.8B-23.8B
Share buybacks-1.39B-20.2B-29.9B-24.1B-19.4B-16.9B-15.3B-15.6B-16.8B-15.1B
Change in cash11.5B808.0M1.86B1.93B-1.51B-3.19B-218.0M-1.53B-1.30B2.61B

Open Financials

Cap table

Built by 6ix from Novo Nordisk A/S Class B’s releases

Common shares
3,333,483,124
Fully diluted
3,333,483,124

Fully diluted

LineShares
Common shares3,333,483,124

Share count over time

CountShares
Nov 22, 20263,333,483,124

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Dodge & Cox20.4MUS$772MSep 30, 2026
Loomis Sayles & Co L P17.9MUS$677MSep 30, 2026
Arrowstreet Capital, Limited Partnership17.1MUS$648MSep 30, 2026
Two Sigma14.9MUS$565MSep 30, 2026
Capital Group14.8MUS$563MSep 30, 2026
Franklin Templeton13.5MUS$571MSep 30, 2026
Bank of America13.5MUS$513MSep 30, 2026
Morgan Stanley13MUS$493MSep 30, 2026
Folketrygdfondet9.46MUS$359MSep 30, 2026
Fisher Asset Management, LLC7.95MUS$301MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Citadel7.01MUS$266MSep 30, 2026
Everett Harris & Co6.47MUS$245MSep 30, 2026
State Farm Mutual Automobile Insurance Co6.14MUS$233MSep 30, 2026
Goldman Sachs5.69MUS$216MSep 30, 2026
State Street5.66MUS$219MSep 30, 2026
Voloridge Investment Management, LLC5.51MUS$209MSep 30, 2026
RBC5.5MUS$209MSep 30, 2026
UBS4.92MUS$186MSep 30, 2026
Renaissance Technologies4.68MUS$177MSep 30, 2026
Wells Fargo4.2MUS$159MSep 30, 2026
Envestnet Asset Management Inc4.12MUS$156MSep 30, 2026
Susquehanna4.05MUS$153MSep 30, 2026
BlackRock3.67MUS$139MSep 30, 2026
Nuveen3.51MUS$133MSep 30, 2026
Barclays3.43MUS$130MSep 30, 2026
T. Rowe Price3.36MUS$127MSep 30, 2026
Saratoga Research & Investment Management3.18MUS$121MSep 30, 2026
Raymond James Financial Inc2.93MUS$111MSep 30, 2026
Markel Group Inc.2.87MUS$109MSep 30, 2026
Northern Trust2.86MUS$108MSep 30, 2026
Natixis2.39MUS$90.7MSep 30, 2026
Fayez Sarofim & Co2.35MUS$89.2MSep 30, 2026
Marshall Wace, LLP2.16MUS$82MSep 30, 2026
Millennium2.15MUS$81.5MSep 30, 2026
Fidelity2.13MUS$80.7MSep 30, 2026
BNP Paribas1.99MUS$75.6MSep 30, 2026
American Century1.84MUS$69.6MSep 30, 2026
Natixis Advisors, LLC1.74MUS$66.1MSep 30, 2026
JPMorgan1.72MUS$65.9MSep 30, 2026
BMO1.66MUS$63MSep 30, 2026
Rockefeller Capital Management L.P.1.66MUS$62.8MSep 30, 2026
VanEck1.53MUS$57.8MSep 30, 2026
Wcm Investment Management, LLC1.49MUS$56.9MSep 30, 2026
Stifel Financial Corp1.46MUS$55.5MSep 30, 2026
Causeway Capital Management LLC1.46MUS$55.3MSep 30, 2026
Ameriprise1.46MUS$55.8MSep 30, 2026
Walleye Capital LLC1.43MUS$54.2MSep 30, 2026
Citigroup Inc1.43MUS$54MSep 30, 2026
LPL Financial LLC1.42MUS$53.8MSep 30, 2026
Dimensional1.39MUS$52.6MSep 30, 2026

This page holds 50 of 1,224 holders. Open Shareholders

Funds

HolderSharesValueAs of
Vanguard Total International Stock Index Fund46.9MUS$2.22BJul 31, 2026
EUPAC Fund36.2MUS$1.74BJun 30, 2026
Vanguard Developed Markets Index Fund31.1MUS$1.49BJun 30, 2026
Capital World Growth & Income Fund26MUS$1.19BMay 31, 2026
iShares Core MSCI EAFE ETF23.9MUS$1.13BJul 31, 2026
Income Fund of America17.8MUS$841MJul 31, 2026
Dodge & Cox Stock Fund15.4MUS$731MJun 30, 2026
Dodge & Cox International Stock Fund13.1MUS$628MJun 30, 2026
Fidelity International Index Fund12.1MUS$554MMay 31, 2026
iShares MSCI EAFE ETF11.4MUS$539MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Capital Income Builder10.3MUS$488MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account9.6MUS$460MJun 30, 2026
New Perspective Fund9.38MUS$450MJun 30, 2026
Causeway International Value Fund8.52MUS$410MJun 30, 2026
Putnam Large Cap Value Fund8.08MUS$375MJul 31, 2026
Vanguard European Stock Index Fund7.62MUS$360MJul 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund7.58MUS$359MJul 31, 2026
Fidelity SAI International Value Index Fund7.23MUS$342MJul 31, 2026
Schwab International Equity ETF7.08MUS$324MMay 31, 2026
New World Fund Inc6.47MUS$306MJul 31, 2026
Fidelity Series Global ex U.S. Index Fund6.4MUS$303MJul 31, 2026
American Funds Fundamental Investors6.3MUS$302MJun 30, 2026
Washington Mutual Investors Fund5.41MUS$251MJul 31, 2026
Vanguard International Dividend Appreciation Index Fund5.21MUS$247MJul 31, 2026
Nuveen International Equity Index Fund5.2MUS$246MJul 31, 2026
Loomis Sayles Growth Fund5.18MUS$245MJun 30, 2026
Vanguard International Growth Fund5.11MUS$234MMay 31, 2026
iShares MSCI EAFE Growth ETF4.95MUS$234MJul 31, 2026
American Balanced Fund4.81MUS$228MJun 30, 2026
New Economy Fund4.76MUS$217MMay 31, 2026
T. Rowe Price Overseas Stock Fund4.68MUS$221MJul 31, 2026
Six Circles International Unconstrained Equity Fund4.63MUS$222MJun 30, 2026
iShares Core MSCI Total International Stock ETF4.42MUS$209MJul 31, 2026
Vanguard International Value Fund4.29MUS$203MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF3.83MUS$184MJun 30, 2026
Vanguard International High Dividend Yield Index Fund3.64MUS$172MJul 31, 2026
International Growth and Income Fund3.62MUS$174MJun 30, 2026
iShares Core MSCI International Developed Markets ETF3.49MUS$165MJul 31, 2026
Capital Group International Focus Equity ETF3.34MUS$153MMay 31, 2026
Vanguard Health Care Fund3.32MUS$157MJul 31, 2026
iShares MSCI Intl Quality Factor ETF3.27MUS$154MJul 31, 2026
MFS International Equity Fund3.12MUS$150MJun 30, 2026
College Retirement Equities Fund - Global Equities Account2.81MUS$135MJun 30, 2026
International Core Equity 2 Portfolio2.71MUS$128MJul 31, 2026
Vanguard Total World Stock Index Fund2.71MUS$128MJul 31, 2026
T. Rowe Price International Stock Fund2.68MUS$124MJul 31, 2026
Six Circles Managed Equity Portfolio International Unconstrained Fund2.62MUS$126MJun 30, 2026
Nuveen International Equity Fund2.52MUS$119MJul 31, 2026
Invesco Comstock Fund2.51MUS$119MJul 31, 2026
Templeton Growth Fund, Inc.2.28MUS$104MMay 31, 2026

This page holds 50 of 632 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Britt Meelby JensenMember of the Board of Directors, member of the Remuneration Committee and member of the Research & Development Committee · Since at least Feb 20, 2026
Cees de JongVice chair of the Board of Directors, chair of the Remuneration Committee, member of the Chair Committee, and member of the Audit Committee · Since at least Feb 20, 2026
Désirée Jantzen AsgreenMember of the Board of Directors (employee representative) and member of the Research & Development Committee · Since at least Nov 5, 2026
Elin JägerSenior Vice President, Chief of Staff to CEO, Transformation & Sustainability · Since at least Nov 14, 2025
Elisabeth Dahl ChristensenMember of the Board of Directors (employee representative) and member of the Remuneration Committee · Since at least Nov 13, 2025
Emil Kongshøj LarsenExecutive Vice President, Head of North America · Since at least Jun 11, 2026
Helena SaxonMember of the Board of Directors, member of the People & Governance Committee and member of the Audit Committee · Since at least Feb 20, 2026
Hong ChowExecutive Vice President, Chief Financial Officer · Since at least Nov 5, 2026
Jamey MillarExecutive Vice President, US Operations · Since at least Apr 2, 2026
Jan van de WinkelMember of the Board of Directors and chair of the Research & Development Committee · Since at least Feb 20, 2026
All 23 people
PersonSeat
Karsten Munk KnudsenExecutive Vice President, Global Operations · Since at least Nov 5, 2026
Kasim KutayMember of the Board of Directors, member of the Research & Development Committee · Since at least Feb 20, 2026
Kasper Bødker MejlvangExecutive Vice President, Global Manufacturing & Supply · Since at least Mar 2, 2026
Lars Rebien SørensenChair of the Board of Directors, chair of the Chair Committee and the People & Governance Committee · Until Oct 21, 2025 · Past
Martin Holst LangeExecutive Vice President, Global Commercial Strategy and Corporate Affairs · Since at least Sep 29, 2026
Maziar Mike DoustdarExecutive Vice President, Global R&D · Since at least Nov 5, 2026
Mette Bøjer JensenMember of the Board of Directors (employee representative), member of the Audit Committee · Since at least Nov 13, 2025
Ramona SequeiraMember of the Board of Directors, member of the Remuneration Committee and member of the Research & Development Committee · Since at least Feb 20, 2026
Semsi Kilic MadsenMember of the Board of Directors (employee representative) and member of the People & Governance Committee · Since at least Nov 5, 2026
Stephan EngelsMember of the Board of Directors, chair of the Audit Committee and member of the People & Governance Committee · Since at least Feb 20, 2026
Tania SabroeExecutive Vice President, People, Organisation & Corporate Affairs · Since at least Sep 14, 2026
Thilde Hummel BøgebjergExecutive Vice President, Global Marketing · Since at least Nov 5, 2026
Thomas Rask NielsenSenior Vice President, Group General Counsel & Legal, Ethics & Compliance, Business Assurance, IP & Security · Since at least Nov 5, 2026

Open People

Log in to ask 6ix AI your own questions about Novo Nordisk A/S.